Coronavirus vaccine: Moderna announces positive interim Phase 1 data
by Press Release from Outbreak News Today on (#53MZ0)
Clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, Inc., announced Monday positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Immunogenicity data are currently available for the 25 [...]
The post Coronavirus vaccine: Moderna announces positive interim Phase 1 data appeared first on Outbreak News Today.